Baystate Wealth Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-480
Closed -$13K 880
2021
Q4
$13K Hold
480
﹤0.01% 521
2021
Q3
$13K Hold
480
﹤0.01% 489
2021
Q2
$14K Buy
+480
New +$14.5K ﹤0.01% 465
2019
Q1
Sell
-300
Closed -$7K 667
2018
Q4
$7K Buy
300
+148
+97% +$3.52K ﹤0.01% 406
2018
Q3
$4K Hold
152
﹤0.01% 447
2018
Q2
$4K Hold
152
﹤0.01% 465
2018
Q1
$3K Buy
152
+3
+2% +$56 ﹤0.01% 464
2017
Q4
$3K Buy
+149
New +$2.36K ﹤0.01% 464

Other funds holding BHC

Baystate Wealth Management's BHC Position: Q1 2022 in Review

Baystate Wealth Management sold out of Bausch Health (BHC) in Q1 2022, closing a stake of 480 shares — an estimated $13K sold.

Baystate Wealth Management first reported a position in BHC in Q4 2017 and held it in 8 quarters. The position peaked at $14K in Q2 2021. 370 funds tracked by Wall St. Rank hold BHC as of Q1 2022.

  • Baystate Wealth Management reported no remaining Bausch Health position as of Q1 2022 after selling out during the quarter.
  • Baystate Wealth Management sold 480 Bausch Health shares in Q1 2022, an estimated $13K.
  • Baystate Wealth Management first reported a position in Bausch Health in Q4 2017 and held it in 8 quarters.
  • Baystate Wealth Management's Bausch Health position peaked at $14K in Q2 2021.
  • 370 funds tracked by Wall St. Rank held Bausch Health as of Q1 2022.

Based on Baystate Wealth Management's 13F filing for Q1 2022, filed 19 Apr 2022.